SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-05-013146
Filing Date
2005-03-28
Accepted
2005-03-28 17:44:13
Documents
1
Period of Report
2005-03-24

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3825
  Complete submission text file 0001104659-05-013146.txt   5467
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Issuer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TRANSKARYOTIC THERAPIES INC 700 MAIN STREET CAMBRIDGE MA 02139
Business Address
ASTRUE MICHAEL J (Reporting) CIK: 0001236367 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21481 | Film No.: 05707532